News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Competitive Technologies, Inc. (CTCC) on Independent Research


6/4/2013 9:38:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FAIRFIELD, Conn., June 4, 2013 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) markets and sells the CalmareĀ® medical device for the treatment of neuropathic pain. CTTC encourages investigators to conduct independent clinical trials involving the Calmare device to add to the growing body of research supporting the efficacy of Calmare in treating chronic neuropathic pain.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES